Sickle cell patients share delight over approval of new treatment
A cutting-edge gene therapy has been approved for NHS use for some patients with severe sickle cell disease.Casgevy, also ...
Axsome Therapeutics Hosts SYMBRAVO® FDA Approval Virtual Investor Event with Expert ...
The Axsome management team will provide an overview of SYMBRAVO and anticipated commercial plans. The presenters will be available to answer questions at the end of the presentation. To access the ...
The Actual Benefits of Red Light Therapy, According to Doctors
Other research has shown red light therapy could minimize the appearance of wrinkles, hyperpigmentation, and broken blood ...
Central Illinois Proud4 小时
New type of non-opioid pain medication approved by FDA
( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first ...
Isle Of Wight Radio4 小时
'Groundbreaking' sickle cell treatment to be offered to NHS patients for first time
A groundbreaking £1.65 million treatment has been approved for use on the NHS, offering patients with severe sickle cell ...
'Hope of a cure': Revolutionary gene-editing therapy for sickle cell approved for use on NHS
NHS officials estimate around 50 people a year will receive treatment now it has been approved for use for certain patients with severe sickle cell disease. | ITV National News ...
AFP6 小时
Vertex Announces CASGEVY® Reimbursement Agreement for the Treatment of Sickle Cell Disease ...
Vertex Pharmaceuticals (Nasdaq: VRTX) announced today a reimbursement agreement with NHS England for eligible sickle cell disease (SCD) patients to access the CRISPR/Cas9 gene-edited therapy, CASGEVY® ...
Sickle cell disease ‘cure’ to be offered to NHS patients
Around 1,700 people could be eligible for the one-time treatment, which is seen as a less risky alternative to a donor stem ...
A £1.65m hope for blood disorder patients is now on offer in Manchester
A £1.65 million treatment has been approved for use for some NHS patients, offering hope of a cure to those with an inherited ...
NHS rolls out revolutionary disease 'cure' costing £1.65million
A revolutionary gene therapy treatment costing a staggering £1.65 million has been approved for NHS use, offering patients ...
FDA approves painkiller designed to eliminate the risk of addiction associated with opioids
WASHINGTON — Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and ...
Groundbreaking £1.65m gene-editing therapy approved for NHS use offers hope to severe ...
The UK has approximately 17,500 individuals living with sickle cell disease, a condition particularly prevalent amongst those ...